A securities class action has been filed against Boston Scientific Corporation (BSX) on behalf of all investors who purchased or otherwise acquired Boston Scientific common stock between July 23, 2025 through February 3, 2026. This case has been filed in the USDC – MA.
On February 4, 2026, Boston Scientific released its fourth quarter 2025 financial results, reporting lower-than-expected sales in its electrophysiology division.
On this news, Boston Scientific’s stock price fell $16.12 per share, or 17.6%, to close at $75.50 per share on February 4, 2026.